Brand Name: Canglob P
(Heterologous parvovirus immunoglobulins / antibodies for dogs)
Manufactured by: Dyntec Spol S.R.O.
Dosage form: Injection (Suspension)
1 x 6 ml, 1 x 5 ml, 6 x 5 ml
All sizes may not be available / marketed.
Ingredients & Composition:
Per dose of 1.0 ml Canglob P contains:
Canine Parvovirus immunoglobulins / antibodies NLT 1024 HIU
(HIU – Hemagglutination-inhibition titre, in a sample dilution, when 50% frequency of complete hemagglutination evoked by virus in a given work dose)
Thiomersal NMT 0.1 mg,
Diluting medium 1.0 ml.
Description / Action:
Canglob P is liquid suspension containing purified hyperimmune immunoglobulins / antibodies (IgY) to ensure passive immunization of dogs against parvovirus, for therapeutic / treatment and prophylactic use. Disease / virus / pathogen specific antibodies facilitate to prevent the development of disease or if they already run – to alleviate its course.
Class: Biologicals / Dog / Parvo immunoglobulins
Indication / Uses:
Canglob P is indicated for passive immunisation against canine parvovirus infection
- Treatment / Therapeutic
They are used to provide passive immunity in animals, for which active immunization is not suitable, mostly in weakened animals, before transfers and exposed to various other stress factors.
Dosage and administration:
0.4 ml / kg body weight (irrespective of breed, age and sex).
Canglob P suspension / parvovirus antibodies should be administered intravenously / intramuscularly or subcutaneously.
Therapeutic dosage should be administered daily until improvement of the health status (it may be use in ill animals).
The preventive / prophylactic dose is 0.4 ml / kg of body weight given at 5-day intervals (it may be used in cases of an immediate endangerment by a disease).
The highest daily dose is 0.4 ml / kg of body weight, which may be used both for therapy and prophylaxis.
The length of therapy of the prophylactic protection and the route of administration should be assessed by a veterinarian.
Onset and Duration of immunity:
Dose 0.4 ml / kg of body weight stimulates passive immunity for a period of approximately 5 days.
Passive immunity develops in dependence on a route of administration. Its duration is dependent on an amount of the product administered as well as on frequency of replications of the administration. On intravenous administration, an immediate onset of the passive immunity is recorded. But utilization of immunoglobulins is the highest. After intramuscular and subcutaneous administration, a slightly delayed onset of the passive immunity is recorded as well as immunity being lower as compared with the i.v. administration.
Overdoses / Side effects / Contraindications /Warnings:
Do not use for prophylactic use in sensitized animals or on an onset of allergic and anaphylactic reactions in cases of repeated utilization.
Active immunization against infectious agents contained in the product is recommended 7 days after the last administration.
Pharmaceutical precautions / Instructions:
Store between 2 °C and 8 °C. Do not freeze. For animal treatment only. Veterinary medicinal product to be supplied only on veterinary prescription.
Safety: Age / Pregnancy/ Withdrawal:
Age related safety and use in pregnant and lactating bitches have not been stated by the manufacturer.
Habit forming: No.
Substitute: Updating Soon